NYSE: BMYBristol Myers Squibb Co Revenue
Bristol Myers Squibb Co revenue was $48.30B for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $12.3B, up 3.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BMY annual revenue was $48.3B, with 7.3% growth year-over-year.
BMY past revenue growth
How has BMY's revenue growth performed historically?
Company
7.32%
Industry
13.95%
Market
19.72%
BMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BMY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BMY's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
BMY revenue history
Current Revenue
$48.3B
Current Earnings
-$8.9B
Current Profit Margin
-18.5%
Be the first to know when BMY announces revenue.
BMY Revenue History By Year
| BMY Yearly Revenue | BMY Revenue | BMY Change | BMY Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $48.30B | $3.29B | +7.32% |
| 2023-12-31 | $45.01B | -$1.15B | -2.50% |
| 2022-12-31 | $46.16B | -$226.00M | -0.49% |
| 2021-12-31 | $46.39B | $3.87B | +9.09% |
| 2020-12-31 | $42.52B | $16.37B | +62.62% |
| 2019-12-31 | $26.15B | $3.58B | +15.89% |
| 2018-12-31 | $22.56B | $1.79B | +8.59% |
| 2017-12-31 | $20.78B | $1.35B | +6.94% |
| 2016-12-31 | $19.43B | $2.87B | +17.31% |
| 2015-12-31 | $16.56B | $681.00M | +4.29% |
| 2014-12-31 | $15.88B | -$506.00M | -3.09% |
| 2013-12-31 | $16.39B | -$1.24B | -7.01% |
| 2012-12-31 | $17.62B | -$3.62B | -17.05% |
| 2011-12-31 | $21.24B | $1.76B | +9.03% |
| 2010-12-31 | $19.48B | $676.00M | +3.59% |
| 2009-12-31 | $18.81B | $1.09B | +6.17% |
| 2008-12-31 | $17.72B | $2.10B | +13.43% |
| 2007-12-31 | $15.62B | -$591.00M | -3.65% |
| 2006-12-31 | $16.21B | -$2.40B | -12.88% |
| 2005-12-31 | $18.61B | -$775.00M | -4.00% |
| 2004-12-31 | $19.38B | $727.00M | +3.90% |
| 2003-12-31 | $18.65B | $2.45B | +15.09% |
| 2002-12-31 | $16.21B | -$1.84B | -10.18% |
| 2001-12-31 | $18.04B | $506.00M | +2.89% |
| 2000-12-31 | $17.54B | $1.04B | +6.28% |
| 1999-12-31 | $16.50B | $1.44B | +9.57% |
| 1998-12-31 | $15.06B | -$1.64B | -9.82% |
| 1997-12-31 | $16.70B | $1.64B | +10.86% |
| 1996-12-31 | $15.07B | $1.30B | +9.43% |
| 1995-12-31 | $13.77B | $1.78B | +14.88% |
| 1994-12-31 | $11.98B | $571.00M | +5.00% |
| 1993-12-31 | $11.41B | $257.00M | +2.30% |
| 1992-12-31 | $11.16B | $585.00M | +5.53% |
| 1991-12-31 | $10.57B | N/A | N/A |
Bristol Myers Squibb Co Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.